跳至主要内容
临床试验/NCT00002052
NCT00002052已完成不适用

Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

University of Southern California1 个研究点 分布在 1 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
1

研究概览

简要总结

To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Exclusion Criteria
  • •Co-existing Condition:
  • •Patients with the following are excluded:
  • •Type I hypersensitivity to beta-lactam antibiotics.
  • •Not expected to survive 12 weeks.
  • •In a coma or with other central nervous system (CNS) impairment.
  • •Patients with the following are excluded:
  • •Type I hypersensitivity to beta-lactam antibiotics.
  • •Not expected to survive 12 weeks.
  • •In a coma or with other central nervous system (CNS) impairment.
  • •Prior Medication:
  • •Excluded within 48 hours of study entry:
  • •Treatment with an antibiotic active in vitro against Salmonella.
  • •HIV infection, AIDS, or AIDS related complex (ARC).
  • •Salmonella bacteremia or positive stool culture in patient with 3 or more stools per day.

排除标准

  • 未提供

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验